Treatment with RT and anti-CTLA-4 was effective at controlling the primary irradiated tumor and extending significantly mice survival compared to control (median survival 41 versus 32.5 days, p < 0.05) (Figure 4B and C), as previously shown [29]. This evidence concerns the gene CTLA4 and neoplasm.